Described herein are pharmaceutical packaging programs which avoid oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medication, these types of devices which includes a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely very low permeabilit